Antiplatelet Removal and HemocompatIbility Events with the HeartMate 3 Pump
Brief description of study
The HeartMate 3 requires medicines to keep your blood from clotting knowing as “blood thinners” which can both be anticoagulants and antiplatelet drugs. The standard drugs given when you have the HeartMate 3 are warfarin and aspirin. This study is investigating whether the combination of these drugs as compared to warfarin alone causes more bleeding without the benefit of preventing more blood clots.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Heart Failure
-
Age: - 99 Years
-
Gender: All
Subject will HeartMate
Updated on
03 Apr 2024.
Study ID: 843216